Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H

Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H

Abstract Background Sulfadoxine-pyrimethamine (SP) is the only anti-malarial drug formulation approved for intermittent preventive treatment in pregnancy (IPTp). However, mutations in the Plasmodium falciparum dhfr (Pfdhfr) and dhps (Pfdhps) genes confer resistance to pyrimethamine and sulfadoxine,...

Full description

Bibliographic Details
Main Authors: M. Andreína Pacheco, Kristan A. Schneider, Qiuying Cheng, Elly O. Munde, Caroline Ndege, Clinton Onyango, Evans Raballah, Samuel B. Anyona, Collins Ouma, Douglas J. Perkins, Ananias A. Escalante
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Malaria Journal
Subjects:
Drug resistance genes
Dhfr
Dhps
k13 gene
SP resistance
Plasmodium falciparum
Online Access:http://link.springer.com/article/10.1186/s12936-020-03454-8

Internet

http://link.springer.com/article/10.1186/s12936-020-03454-8

Similar Items